This helped us to confirm the presence of Cyr61 in CTC from cancer patients, as our detection approach was suited to a CK5/Cyr61 positive phenotype like BC-M1, but could also detect CTCs with a high degree of epithelial differentiation. This evidence concerns the gene CCN1 and cancer.